二叶式主动脉瓣形态与经导管主动脉瓣置换术后结局
基于国际多中心BAV TAVR注册研究,1034例CT确诊的二叶式主动脉瓣狭窄患者接受新一代器械TAVR,30天、1年、2年全因死亡率分别为2.0%、6.7%、12.5%。钙化嵴与过度瓣叶钙化是2年全因死亡的独立预测因素,两者并存者2年死亡率达25.7%。
要点
- 二叶式主动脉瓣TAVR结局取决于瓣膜形态,钙化嵴与过度瓣叶钙化增加并发症和中期死亡风险。
- 钙化嵴合并过度瓣叶钙化者2年全因死亡率25.7%,显著高于仅1项或均无者(9.5% vs 5.9%)。
- 两者并存者主动脉根部损伤、中重度瓣周反流和30天死亡率均更高。
核心结论
- 二叶式主动脉瓣狭窄患者TAVR结局取决于瓣膜形态,钙化嵴和过度瓣叶钙化与手术并发症及中期死亡风险增加相关。
研究设计与样本
- 国际多中心B族主动脉瓣TAVR注册研究(NCT03836521),纳入经中心核心实验室CT确认的二叶式主动脉瓣患者1034例,平均年龄74.7岁,STS评分3.7%。
- 使用当代器械:Sapien 3共740例,Evolut R/Pro共188例,其他器械106例。
- CT盲法评估二叶式主动脉瓣形态,包括嵴数量、嵴钙化分级和瓣叶钙化体积。
主要发现
- 30天、1年和2年全因死亡率分别为2.0%、6.7%和12.5%。
- 多变量分析显示钙化嵴和过度瓣叶钙化(定义为超过中位钙化体积)是2年全因死亡的独立预测因素。
- 钙化嵴合并过度瓣叶钙化者269例(26.0%),其2年全因死亡率显著高于仅1项或均无者(25.7% vs 9.5% vs 5.9%;log-rank p < 0.001)。
- 两者并存者主动脉根部损伤(p < 0.001)、中重度瓣周反流(p = 0.002)和30天死亡率(p = 0.016)均更高。
临床怎么用
- 对二叶式主动脉瓣狭窄患者行TAVR前应通过CT评估嵴钙化和瓣叶钙化体积,以识别高危形态。
- 钙化嵴合并过度瓣叶钙化者手术并发症和中期死亡风险较高,需谨慎评估并加强围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bicuspid aortic stenosis accounts for almost 50% of patients undergoing surgical aortic valve replacement in the younger patients. Expanding the indication of transcatheter aortic valve replacement (TAVR) toward lower-risk and younger populations will lead to increased use of TAVR for patients with bicuspid aortic valve (BAV) stenosis despite the exclusion of bicuspid anatomy in all pivotal clinical trials. OBJECTIVES: This study sought to evaluate the association of BAV morphology and outcomes of TAVR with the new-generation devices. METHODS: Patients with BAV confirmed by central core laboratory computed tomography (CT) analysis were included from the international multicenter BAV TAVR registry. BAV morphology including the number of raphe, calcification grade in raphe, and leaflet calcium volume were assessed with CT analysis in a masked fashion. Primary outcomes were all-cause mortality at 1 and 2 years, and secondary outcomes included 30-day major endpoints and procedural complications. RESULTS: A total of 1,034 CT-confirmed BAV patients with a mean age of 74.7 years and Society of Thoracic Surgeons score of 3.7% underwent TAVR with contemporary devices (n = 740 with Sapien 3; n = 188 with Evolut R/Pro; n = 106 with others). All-cause 30-day, 1-year, and 2-year mortality was 2.0%, 6.7%, and 12.5%, respectively. Multivariable analysis identified calcified raphe and excess leaflet calcification (defined as more than median calcium volume) as independent predictors of 2-year all-cause mortality. Both calcified raphe plus excess leaflet calcification were found in 269 patients (26.0%), and they had significantly higher 2-year all-cause mortality than those with 1 or none of these morphological features (25.7% vs. 9.5% vs. 5.9%; log-rank p < 0.001). Patients with both morphological features had higher rates of aortic root injury (p < 0.001), moderate-to-severe paravalvular regurgitation (p = 0.002), and 30-day mortality (p = 0.016). CONCLUSIONS: Outcomes of TAVR in bicuspid aortic stenosis depend on valve morphology. Calcified raphe and excess leaflet calcification were associated with increased risk of procedural complications and midterm mortality. (Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry; NCT03836521).
引用
- Yoon SH, Kim WK, Dhoble A, et al. Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020. PMID: 32854836. doi:10.1016/j.jacc.2020.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。